The world-wide market share of biologic drugs is advancing at a staggering pace, with some estimates ranging from $ 300 billion to $452 billion in revenue within the next five years.[1],[2],[3] The treatment costs for patients administered biologic drugs are very high relative to historic drug prices. The one year
